WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced ...

RELiZORB is a digestive enzyme cartridge designed to mimic the function of pancreatic lipase to provide nutritional support for enterally-fed patients. To meet the feeding needs of neonates and ...

The activity of enzymes in industrial processes, laboratories, and living beings can be remotely controlled using light. This requires their immobilization on the surface of nanoparticles and ...

Alcresta has received de novo approval from the FDA to market Relizorb (immobilized lipase), a first-of-its kind digestive enzyme cartridge that breaks down fats in enteral tube feeding formula to ...

Enzyme engineering is an enzyme technology. With the rapid development of enzymology research, especially the promotion of enzyme application, the basic principle of enzymology is combined with ...

WARREN, N.J.--(BUSINESS WIRE)--Alcresta Therapeutics, Inc. announced the issuance of a permanent and unique billing code by the Centers for Medicare and Medicaid Services (CMS) for RELiZORB. RELiZORB ...

(RTTNews) - Ecovyst Inc. (ECVT), a global leader in advanced materials and specialty catalysts, has signed a Memorandum of Understanding - MOU with Enzyme Supplies Ltd, a key player in industrial ...

Here's some good news for anyone looking to rev up their metabolism, the fire that burns calories. Scientists announced this week that they'd discovered a way to manipulate lipase, the enzyme that ...